These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17567509)

  • 1. Canine obesity: an overview.
    Gossellin J; Wren JA; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():1-10. PubMed ID: 17567509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs.
    Wren JA; King VL; Campbell SL; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():33-42. PubMed ID: 17567513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dirlotapide: a review of its properties and role in the management of obesity in dogs.
    Wren JA; Gossellin J; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():11-6. PubMed ID: 17567510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dog obesity: owner attitudes and behaviour.
    Bland IM; Guthrie-Jones A; Taylor RD; Hill J
    Prev Vet Med; 2009 Dec; 92(4):333-40. PubMed ID: 19766333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dirlotapide, a microsomal triglyceride transfer protein inhibitor, on the digestibility of a dry expanded diet in adult dogs.
    Kirk CA; Boucher JF; Sunderland SJ; Wren JA
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():66-72. PubMed ID: 17567516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss effect of dietary diacylglycerol in obese dogs.
    Umeda T; Bauer JE; Otsuji K
    J Anim Physiol Anim Nutr (Berl); 2006 Jun; 90(5-6):208-15. PubMed ID: 16684141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dirlotapide in the management of obese dogs evaluated in two placebo-controlled, masked clinical studies in North America.
    Wren JA; Ramudo AA; Campbell SL; King VL; Eagleson JS; Gossellin J; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():81-9. PubMed ID: 17567518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a canine weight-loss program in clinical practice.
    Saker KE; Remillard RL
    Vet Ther; 2005; 6(4):291-302. PubMed ID: 16550491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foods and techniques for managing obesity in companion animals.
    Burkholder WJ; Bauer JE
    J Am Vet Med Assoc; 1998 Mar; 212(5):658-62. PubMed ID: 9524636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based review of the use of therapeutic foods, owner education, exercise, and drugs for the management of obese and overweight pets.
    Roudebush P; Schoenherr WD; Delaney SJ
    J Am Vet Med Assoc; 2008 Sep; 233(5):717-25. PubMed ID: 18764704
    [No Abstract]   [Full Text] [Related]  

  • 11. Canine and feline obesity: frequently asked questions and their answers.
    Becvarova I
    Compend Contin Educ Vet; 2011 Nov; 33(11):E2. PubMed ID: 22101449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of dirlotapide in dogs.
    Wren JA; King VL; Krautmann MJ; Gossellin J; Kerlin RL; Hickman MA; Schmahai TJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():43-54. PubMed ID: 17567514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and managing obesity in dogs and cats.
    Laflamme DP
    Vet Clin North Am Small Anim Pract; 2006 Nov; 36(6):1283-95, vii. PubMed ID: 17085235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity in a dog, with secondary hormonal imbalance.
    Stogdale L; Moore DJ
    J S Afr Vet Assoc; 1980 Mar; 51(1):41-5. PubMed ID: 7005442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dirlotapide for sustained weight loss in overweight Labrador retrievers.
    Gossellin J; Peachey S; Sherington J; Rowan TG; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():55-65. PubMed ID: 17567515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity Treatment: Environment and Behavior Modification.
    Murphy M
    Vet Clin North Am Small Anim Pract; 2016 Sep; 46(5):883-98. PubMed ID: 27264054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of obesity--the clinical nutritionist's experience.
    Buffington CA
    Int J Obes Relat Metab Disord; 1994 Jun; 18 Suppl 1():S29-35. PubMed ID: 8087162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of dirlotapide to reduce body weight of client-owned dogs in two placebo-controlled clinical studies in Europe.
    Gossellin J; McKelvie J; Sherington J; Wren JA; Eagleson JS; Rowan TG; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():73-80. PubMed ID: 17567517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition and osteoarthritis in dogs: does it help?
    Budsberg SC; Bartges JW
    Vet Clin North Am Small Anim Pract; 2006 Nov; 36(6):1307-23, vii. PubMed ID: 17085237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of starting condition score to estimate changes in body weight and composition during weight loss in obese dogs.
    German AJ; Holden SL; Bissot T; Morris PJ; Biourge V
    Res Vet Sci; 2009 Oct; 87(2):249-54. PubMed ID: 19303120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.